These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 27042741)
21. Asfotase alfa improved skeletal mineralization and fracture healing in a child with MCAHS. Kang M; Wu M; Crane JL Bone; 2023 Jul; 172():116778. PubMed ID: 37088336 [TBL] [Abstract][Full Text] [Related]
22. A Bone Histomorphometric Analysis of Hypophosphatasia-related Osteoporosis after Teriparatide Treatment. Mizuno H; Sawa N; Sekine A; Inoue N; Oba Y; Ikuma D; Yamanouchi M; Hasegawa E; Suwabe T; Suzuki H; Hoshino J; Ubara Y Intern Med; 2023 Jan; 62(1):75-79. PubMed ID: 35650135 [TBL] [Abstract][Full Text] [Related]
23. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Baumgartner-Sigl S; Haberlandt E; Mumm S; Scholl-Bürgi S; Sergi C; Ryan L; Ericson KL; Whyte MP; Högler W Bone; 2007 Jun; 40(6):1655-61. PubMed ID: 17395561 [TBL] [Abstract][Full Text] [Related]
24. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis. Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205 [TBL] [Abstract][Full Text] [Related]
25. Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. Gomberg SJ; Wustrack RL; Napoli N; Arnaud CD; Black DM J Clin Endocrinol Metab; 2011 Jun; 96(6):1627-32. PubMed ID: 21430030 [TBL] [Abstract][Full Text] [Related]
26. Recurrent Metatarsal Fractures in Postmenopausal Woman With Low Serum Alkaline Phosphatase: A Rare Diagnosis Not to Miss. Iqbal U; Anwar H; Chaudhary A; Alvi M; Freeth A J Investig Med High Impact Case Rep; 2017; 5(3):2324709617718851. PubMed ID: 28748194 [TBL] [Abstract][Full Text] [Related]
27. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa. Seefried L; Rak D; Petryk A; Genest F Osteoporos Int; 2021 Dec; 32(12):2505-2513. PubMed ID: 34215909 [TBL] [Abstract][Full Text] [Related]
28. Healing of vitamin D deficiency rickets complicating hypophosphatasia suggests a role beyond circulating mineral sufficiency for vitamin D in musculoskeletal health. Lin EL; Gottesman GS; McAlister WH; Bijanki VN; Mack KE; Griffin DM; Mumm S; Whyte MP Bone; 2020 Jul; 136():115322. PubMed ID: 32200022 [TBL] [Abstract][Full Text] [Related]
29. Mutational and biochemical findings in adults with persistent hypophosphatasemia. McKiernan FE; Dong J; Berg RL; Scotty E; Mundt P; Larson L; Rai I Osteoporos Int; 2017 Aug; 28(8):2343-2348. PubMed ID: 28401263 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis. Deng J; Feng Z; Li Y; Pan T; Li Q; Zhao C Medicine (Baltimore); 2018 Nov; 97(47):e13341. PubMed ID: 30461654 [TBL] [Abstract][Full Text] [Related]
31. Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study. Hepp N; Frederiksen AL; Duno M; Jørgensen NR; Jensen JB Osteoporos Int; 2022 Dec; 33(12):2595-2605. PubMed ID: 35986118 [TBL] [Abstract][Full Text] [Related]
32. The impact of switching once-weekly teriparatide to denosumab in osteoporosis patients. Miyagi M; Fujimaki H; Naruse K; Suto K; Inoue G; Nakazawa T; Imura T; Saito W; Uchida K; Shirasawa E; Takahira N; Takaso M J Orthop Sci; 2019 Jan; 24(1):153-158. PubMed ID: 30146385 [TBL] [Abstract][Full Text] [Related]
33. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Schmidt T; Mussawy H; Rolvien T; Hawellek T; Hubert J; Rüther W; Amling M; Barvencik F Osteoporos Int; 2017 Sep; 28(9):2653-2662. PubMed ID: 28547134 [TBL] [Abstract][Full Text] [Related]
34. An 18-month open-label trial of teriparatide in patients with previous parathyroidectomy at continued risk for osteoporotic fractures: an exploratory study. Horowitz BS; Horowitz ME; Fonseca S; Ruiz M; Kaye WA Endocr Pract; 2011; 17(3):377-83. PubMed ID: 21134879 [TBL] [Abstract][Full Text] [Related]
35. Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial. Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Koukoulis GN; Efstathiadou Z; Kita M; Avramidis A Int J Clin Pract; 2008 Jun; 62(6):919-24. PubMed ID: 18422590 [TBL] [Abstract][Full Text] [Related]